Investigation of the Hemostatic Effect of a Transdermal Patch Containing 0.55 mg Ethinyl Estradiol and 2.1 mg Gestodene Compared with a Monophasic Oral Contraceptive Containing 0.03 mg Ethinyl Estradiol and 0.15 mg Levonorgestrel: An Open-Label, Randomized, Crossover Study

BACKGROUND: Transdermal delivery of contraceptives offers several advantages over combined oral contraceptives (COCs), including effective absorption and the provision of relatively constant serum concentrations. Ethinyl estradiol (EE) and the progestin gestodene are well-absorbed through the skin a...

Descripción completa

Detalles Bibliográficos
Autores principales: Junge, Wolfgang, Heger-Mahn, Doris, Trummer, Dietmar, Merz, Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2013
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3784047/
https://www.ncbi.nlm.nih.gov/pubmed/24043457
http://dx.doi.org/10.1007/s40268-013-0028-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3784047/
https://www.ncbi.nlm.nih.gov/pubmed/24043457
http://dx.doi.org/10.1007/s40268-013-0028-2

Ejemplares similares